Blackstone slips 6.3% as rate jitters and post-earnings outlook concerns weigh on alternative managers

Blackstone Inc. (BX) is down 6.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears most consistent with a macro-driven risk-off reaction in interest-rate-sensitive financials after a hawkish read-through from recent central bank communications pushed Treasury yields higher. BX had also been in a fragile sentiment window following its late-January results and commentary, where investors have been especially sensitive to forward-looking fee and realization expectations.

Details:

Recent central bank minutes signaled less urgency to cut rates, and Treasury yields moved higher, which can pressure valuation assumptions for long-duration and asset-management businesses.

Blackstone’s fourth-quarter and full-year 2025 results were released on January 29, 2026, including a quarterly dividend declaration of $1.49 per share (paid February 17, 2026), keeping investor focus on distributable earnings and fee-related earnings momentum.

In the weeks following the results, commentary in the market has highlighted heightened sensitivity to 2026 outlook framing, including whether fundraising, performance fees, and realizations can re-accelerate fast enough to support expectations.

This could also be amplified by broader de-risking across alternative asset managers when rates rise, as investors reassess private-asset exit timing and marks.

Sources:

SEC, Blackstone, Financial Times, Trefis

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BX Insider Trading Activity

$BX insiders have traded $BX stock on the open market 9 times in the past 6 months. Of those trades, 6 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $BX stock by insiders over the last 6 months:

JOSEPH BARATTA has made 0 purchases and 2 sales selling 113,000 shares for an estimated $19,853,482.
JAMES BREYER has made 3 purchases buying 27,070 shares for an estimated $3,991,334 and 0 sales.
JOHN G FINLEY (Chief Legal Officer) sold 21,500 shares for an estimated $3,686,390
RUTH PORAT has made 3 purchases buying 402 shares for an estimated $58,835 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BX Hedge Fund Activity

We have seen 1,078 institutional investors add shares of $BX stock to their portfolio, and 993 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 70,132,441 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,982,127,544
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 11,851,280 shares (-73.0%) from their portfolio in Q4 2025, for an estimated $1,826,756,299
JPMORGAN CHASE & CO removed 4,945,060 shares (-19.9%) from their portfolio in Q4 2025, for an estimated $762,231,548
CAPITAL WORLD INVESTORS removed 4,455,811 shares (-27.8%) from their portfolio in Q4 2025, for an estimated $686,818,707
CAPITAL RESEARCH GLOBAL INVESTORS added 3,178,133 shares (+99.2%) to their portfolio in Q4 2025, for an estimated $489,877,420
LAZARD ASSET MANAGEMENT LLC removed 2,131,240 shares (-59.0%) from their portfolio in Q4 2025, for an estimated $328,509,333
EDGEWOOD MANAGEMENT LLC removed 2,112,578 shares (-26.9%) from their portfolio in Q4 2025, for an estimated $325,632,772

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$BX Congressional Stock Trading

Members of Congress have traded $BX stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $BX stock by members of Congress over the last 6 months:

REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 12/11.
REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BX Analyst Ratings

Wall Street analysts have issued reports on $BX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Citizens issued a "Market Outperform" rating on 01/30/2026
JMP Securities issued a "Market Outperform" rating on 10/24/2025
TD Cowen issued a "Buy" rating on 10/24/2025
Morgan Stanley issued a "Overweight" rating on 10/21/2025
BMO Capital issued a "Outperform" rating on 10/03/2025

To track analyst ratings and price targets for $BX, check out Quiver Quantitative's $BX forecast page.

$BX Price Targets

Multiple analysts have issued price targets for $BX recently. We have seen 10 analysts offer price targets for $BX in the last 6 months, with a median target of $177.5.

Here are some recent targets:

Crispin Love from Piper Sandler set a target price of $158.0 on 02/02/2026
Kenneth Worthington from JP Morgan set a target price of $158.0 on 01/30/2026
Bill Katz from TD Cowen set a target price of $183.0 on 01/30/2026
Brian McKenna from Citizens set a target price of $195.0 on 01/30/2026
Benjamin Budish from Barclays set a target price of $164.0 on 01/30/2026
Michael Brown from UBS set a target price of $172.0 on 01/13/2026
Brian McKenna from JMP Securities set a target price of $195.0 on 10/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.